A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for Low Grade Serous Ovarian Cancer
Drug: Avutometinib
38 locations incl. Phoenix
Sponsor: Verastem, Inc.
Sex: Female·Age: 18+
Code: NCT06072781·Phase 3·Recruiting